Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer

Clinical trial NCT05021237 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05021237
Sponsor: University of Texas Southwestern Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IV Cervical Cancer FIGO 2018 Adenosquamous Carcinoma of Cervix Cervical Cancer Metastasis

Start date: 2022-02-01
Primary completion: 2028-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.